Home Special Topics Technology Offerings Content

Novel medical indication of Baclofen and other GABAB receptor specific agonists

next article

10.10.2007

Scientists from the university hospital of Frankfurt am Main found that baclofen significantly improves the medical therapy in a so far unknown field of medical application. Furthermore, the results implicate that other GABAB receptor specific agonists hold a comparative potential. The new indication applies to a multitude of patients mainly in industrialised countries. According to the physicians this means an important enhancement of today?s possibilities of treatment for these patients.

Further Information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/798-49721

Contact
Dr. Otmar Schöller

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

info@technologieallianz.de | Source: TechnologieAllianz e.V.
Further information: www.technologieallianz.de/angebote.php?sort=sag&id=1150&lang=en
www.technologieallianz.de

next article